SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (6522)6/22/1998 6:53:00 PM
From: Tharos  Respond to of 17367
 
Perhaps Castello was too busy at Cholestech Corporation
cholestech.com

Cholestech Corporation (Nasdaq: CTEC) was founded in 1988. The company completed its initial public offering on June 26, 1992 and secondary offerings on December 16, 1992 and June 28, 1996.
Officers
Warren E. Pinckert II
President & CEO
Steven L. Barbato
Vice President, Manufacturing
Gary E. Hewett
Vice President, Research & Development
Mark J. Kussman
Vice President, Sales & Marketing
Andrea J. Tiller
CFO & VP Finance

Board of Directors
Harvey S. Sadow, Ph.D., Chairman
Chairman of the Board (ret.) Boehringer Ingelheim
Joseph Buchman, M.D., Director Member Cardio Thoracic Group
John L. Castello, Director President & CEO Xoma Corporation
Warren E. Pinckert II, Director President & CEO Cholestech
H.R. Shepherd, Director Founder & Chairman of the Board, Albert Sabin Vaccine Foundation



To: aknahow who wrote (6522)6/22/1998 6:55:00 PM
From: Tharos  Read Replies (2) | Respond to of 17367
 
nanolog.com

Perhaps Dr. Scannon was too busy as director of NanoLogic to make the decision on whether or not to release the UK info.